Standout Papers

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prosta... 2015 2026 2018 2022 300
  1. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial (2015)
    Gwénaëlle Gravis, Jean‐Marie Boher et al. European Urology

Citation Impact

1 by Nobel laureates 9 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

TGF-β signaling in health and disease
2023 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
8 intermediate papers

Works of G. Deplanque being referenced

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
2015
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
2010
and 3 more

Author Peers

Author Oncology PRM Surgery Molecular Biology Last Decade Papers Cites
G. Deplanque 1259 788 219 624 76 2.2k
Eduardo Cuervo Reyes 12 415
Janet L. Pitman 16 4 17 138 27 330
Guangming Dong 5 4 10 330
Shijuan Shan 32 17 4 149 35 557
André Hebel 3 1 224 7 566

All Works

Loading papers...

Rankless by CCL
2026